Source: http://www.science.gov/topicpages/r/reimbursement+incentive.html
Timestamp: 2016-09-26 20:44:34
Document Index: 725469410

Matched Legal Cases: ['§ 215', '§ 215', '§ 1485', '§ 219', '§ 215', '§ 765', '§ 765', '§ 765', '§ 765', '§ 765', '§ 765', '§ 765', '§ 765', '§ 765', '§ 400', '§ 765', '§ 404', '§ 416', 'art 31', '§ 645', 'art 31', '§ 645', '§ 1214', '§ 1214', '§ 1214', '§ 220', '§ 310', '§ 310', '§ 310', '§ 310', '§ 310', '§ 94', '§ 1230', '§ 1230', '§ 1230', '§ 1230', '§ 1230', '§ 1230', '§ 1230', '§ 1230', '§ 1230', '§ 94', '§ 94', '§ 94', '§ 94', 'arts 301', 'arts 301', '§ 220', '§ 220', '§ 220', '§ 220', '§ 220', '§ 1214', '§ 1208', '§ 202', '§ 674', '§ 1214', '§ 1214', '§ 1214', '§ 64', '§ 199']

reimbursement incentive: Topics by Science.gov
Sample records for reimbursement incentive
... 48 Federal Acquisition Regulations System 3 2013-10-01 2013-10-01 false Cost-reimbursement incentive contracts. 216.405 Section 216.405 Federal Acquisition Regulations System DEFENSE ACQUISITION REGULATIONS SYSTEM, DEPARTMENT OF DEFENSE CONTRACTING METHODS AND CONTRACT TYPES TYPES OF CONTRACTS...
... 48 Federal Acquisition Regulations System 3 2014-10-01 2014-10-01 false Cost-reimbursement incentive contracts. 216.405 Section 216.405 Federal Acquisition Regulations System DEFENSE ACQUISITION REGULATIONS SYSTEM, DEPARTMENT OF DEFENSE CONTRACTING METHODS AND CONTRACT TYPES TYPES OF CONTRACTS...
Kesteloot, K; Voet, N
Up to now, few analytical models have studied the incentives for cooperation in quality improvements among hospitals. Only those dealing with reimbursement systems have shown that, from the point of view of individual or competing hospitals, retrospective reimbursement is more likely to encourage quality improvements than prospective financing, while the reverse holds for efficiency improvements. This paper studies the incentives to improve the quality of hospital care, in an analytical model, taking into account the possibility of cooperative agreements, price besides non-price (quality) competition and quality improvements that may simultaneously increase demand, increase or reduce costs and spill over to rival hospitals. In this setting quality improvement efforts rise with the rate of prospective reimbursement, while the impact of the rate of retrospective reimbursement is ambiguous, but likely to be negative for quality improvements that are highly cost-reducting and create large spillovers. Cooperation may lead to more or less quality improvement than non-cooperative conduct, depending on the magnitude of spillovers and the degree of product market competition, relative to the net effect of quality on profits and the share of costs that is reimbursed retrospectively. Finally, the stability of cooperative agreements, supported by grim trigger strategies, is shown to depend upon exactly the opposite interaction between these factors. PMID:10339249
Stratified Medicine (SM) has the potential to target patient populations who will most benefit from a therapy while reducing unnecessary health interventions associated with side effects. The link between clinical biomarkers/diagnostics and therapies provides new opportunities for value creation to strengthen the value proposition to pricing and reimbursement (P&R) authorities. However, the introduction of SM challenges current reimbursement schemes in many EU countries and the US as different P&R policies have been adopted for drugs and diagnostics. Also, there is a lack of a consistent process for value assessment of more complex diagnostics in these markets. New, innovative approaches and more flexible P&R systems are needed to reflect the added value of diagnostic tests and to stimulate investments in new technologies. Yet, the framework for access of diagnostic-based therapies still requires further development while setting the right incentives and appropriate align stakeholders interests when realizing long-term patient benefits. This article addresses the reimbursement challenges of SM approaches in several EU countries and the US outlining some options to overcome existing reimbursement barriers for stratified medicine. PMID:23087645
... 48 Federal Acquisition Regulations System 1 2014-10-01 2014-10-01 false Cost-plus-incentive-fee... CONTRACTING METHODS AND CONTRACT TYPES TYPES OF CONTRACTS Cost-Reimbursement Contracts 16.304 Cost-plus-incentive-fee contracts. A cost-plus-incentive-fee contract is a cost-reimbursement contract that...
... 48 Federal Acquisition Regulations System 1 2010-10-01 2010-10-01 false Cost-plus-incentive-fee... CONTRACTING METHODS AND CONTRACT TYPES TYPES OF CONTRACTS Cost-Reimbursement Contracts 16.304 Cost-plus-incentive-fee contracts. A cost-plus-incentive-fee contract is a cost-reimbursement contract that...
... 48 Federal Acquisition Regulations System 1 2013-10-01 2013-10-01 false Cost-plus-incentive-fee... CONTRACTING METHODS AND CONTRACT TYPES TYPES OF CONTRACTS Cost-Reimbursement Contracts 16.304 Cost-plus-incentive-fee contracts. A cost-plus-incentive-fee contract is a cost-reimbursement contract that...
Health care providers may vertically integrate not only to facilitate coordination of care, but also for strategic reasons that may not be in patients’ best interests. Optimal Medicare reimbursement policy depends upon the extent to which each of these explanations is correct. To investigate, we compare the consequences of the 1997 adoption of prospective payment for skilled nursing facilities (SNF PPS) in geographic areas with high versus low levels of hospital/SNF integration. We find that SNF PPS decreased spending more in high integration areas, with no measurable consequences for patient health outcomes. Our findings suggest that integrated providers should face higher-powered reimbursement incentives, i.e., less cost-sharing. More generally, we conclude that purchasers of health services (and other services subject to agency problems) should consider the organizational form of their suppliers when choosing a reimbursement mechanism. PMID:21850551
Changing the rules of the reimbursement game.
Curtiss, F R
Recently enacted federal and state legislation reflect a gradual transition from cost-based reimbursement to rate-based reimbursement for hospital services; the implications of this trend for hospital pharmacists are discussed. Under "The Tax Equity and Fiscal Responsibility Act of 1982," Medicare hospital reimbursement is limited based on total hospital costs, effective for the 1983 fiscal reporting period. In addition, a target limit of costs for each hospital will be computed and hospitals will have positive and negative incentives to keep costs below this amount. These reimbursement changes calculate limits on the basis of costs per case, not costs incurred. These changes increasingly require hospitals to share in the risk of expenditures attributed to use of services. For hospital pharmacists, this means that the focus is changing from maximizing revenue from drug products to controlling unnecessary use and reducing departmental expense. Clinical pharmacy services will survive only if they are shown to be cost effective. Hospital pharmacists cannot afford to ignore the changing patterns of reimbursement; the consequences of unpreparedness and inaction may be decreased budgets and the relegation of hospital pharmacy practice to assembly-line economics. PMID:7148872
... 48 Federal Acquisition Regulations System 1 2014-10-01 2014-10-01 false Cost-plus-incentive-fee... CONTRACTING METHODS AND CONTRACT TYPES TYPES OF CONTRACTS Incentive Contracts 16.405-1 Cost-plus-incentive-fee contracts. (a) Description. The cost-plus-incentive-fee contract is a cost-reimbursement contract...
... 48 Federal Acquisition Regulations System 1 2010-10-01 2010-10-01 false Cost-plus-incentive-fee... CONTRACTING METHODS AND CONTRACT TYPES TYPES OF CONTRACTS Incentive Contracts 16.405-1 Cost-plus-incentive-fee contracts. (a) Description. The cost-plus-incentive-fee contract is a cost-reimbursement contract...
... 48 Federal Acquisition Regulations System 1 2013-10-01 2013-10-01 false Cost-plus-incentive-fee... CONTRACTING METHODS AND CONTRACT TYPES TYPES OF CONTRACTS Incentive Contracts 16.405-1 Cost-plus-incentive-fee contracts. (a) Description. The cost-plus-incentive-fee contract is a cost-reimbursement contract...
[Reimbursement questions in telemedicine].
Weichmann, H
Taking professional law and rumuneration relevance into account physician services that are based on tele-medicine are not reimbursed in Germany. Both the medical fee schedule for private services and the medical fee schedule for statutory health insurance services do not allow reimbursement of tele-medicine, with the exception of simple consultation via phone. PMID:11688221
... incentive contracts. (a) Fixed-price incentive contracts. The TCO shall settle terminated fixed-price...) Partial termination. Under a partially terminated contract, the TCO shall negotiate a settlement as... the settlement proposal. The TCO shall reimburse the contractor at target price for completed...
Harbaugh, Norman Chip
There is urgent need to reform health care reimbursement models, including physician compensation, to address high health care costs, despite numerous quality initiatives. Pay for performance (P4P) is a model that attempts to align financial incentives with better outcomes and value rather than the current system of rewarding volume and intensity of care delivered. P4P has been implemented in other countries besides the United States and is perhaps most advanced in the United Kingdom. Measurement for P4P is evolving, as are the types of incentives; neither is perfect at this time. For P4P to succeed, all health care stakeholders will need to collaborate. PMID:19660642
7 CFR 1485.18 - Reimbursement procedures.
... required to use CCC's Internet-based UES system to request reimbursement for eligible MAP expenses. Claims... reimbursed; (7) If applicable, any reduction in the amount of reimbursement claimed to offset CCC demand for... reimbursement shall be submitted by the MAP Participant's U.S. office to CCC. (c) CCC will not reimburse a...
48 CFR 1552.211-73 - Level of effort-cost-reimbursement term contract.
... contracts without fee, cost-sharing contracts, cost-plus-fixed-fee (CPFF) contracts, cost-plus-incentive-fee contracts (CPIF), and cost-plus-award-fee contracts (CPAF). Level of Effort—Cost-Reimbursement Term Contract... additional effort shall not result in any increase in the fixed fee, if any. If this is a...
A simple methodology to finance public health initiatives: reimbursement for tuberculosis directly observed therapy services in New York State.
Klein, S J; Laufer, F N
New York State (NYS) used Medicaid reimbursement to create incentives for health care providers to offer directly observed therapy (DOT) services for active tuberculosis (TB) disease. This resulted in proliferation of 26 new TB DOT providers and expanded capacity for the New York City (NYC). Department of Health. As a result, over 1,200 individuals now receive DOT in NYC. The reimbursement methodology was also used for other NYS public health initiatives. It is applicable for public health initiatives elsewhere. PMID:10186645
... required to use CCC's Internet-based UES system to request reimbursement for eligible MAP expenses. Claims... reimbursement shall be submitted by the MAP Participant's U.S. office to CCC. (c) CCC will not reimburse a claim for less than $10,000, except that CCC will reimburse a final claim for a MAP Participant's...
... 14 Aeronautics and Space 5 2013-01-01 2013-01-01 false Reimbursement policy. 1214.803 Section 1214.803 Aeronautics and Space NATIONAL AERONAUTICS AND SPACE ADMINISTRATION SPACE FLIGHT Reimbursement for... shall be escalated in accordance with the Shuttle policy. (c) Customers shall reimburse NASA an...
... 14 Aeronautics and Space 5 2011-01-01 2010-01-01 true Reimbursement policy. 1214.803 Section 1214.803 Aeronautics and Space NATIONAL AERONAUTICS AND SPACE ADMINISTRATION SPACE FLIGHT Reimbursement for... shall be escalated in accordance with the Shuttle policy. (c) Customers shall reimburse NASA an...
... 14 Aeronautics and Space 5 2010-01-01 2010-01-01 false Reimbursement policy. 1214.803 Section 1214.803 Aeronautics and Space NATIONAL AERONAUTICS AND SPACE ADMINISTRATION SPACE FLIGHT Reimbursement for... shall be escalated in accordance with the Shuttle policy. (c) Customers shall reimburse NASA an...
Jayaram, Raja; Ramakrishnan, Nagarajan
There are significant variations in critical care practices, costs, and reimbursements in various countries. Of note, there is a paucity of reliable information on remuneration and reimbursement models for intensivists in India. This review article aims to analyze the existing reimbursement models in United States and United Kingdom and propose a frame-work model that may be applicable in India. PMID:23833469
... AGRICULTURE CHILD NUTRITION PROGRAMS SPECIAL MILK PROGRAM FOR CHILDREN § 215.10 Reimbursement procedures. (a... pricing milk program in the same school or child care institution, may elect to claim reimbursement for... by FNS, the Claim for Reimbursement for any month shall include only milk served in that month...
... AGRICULTURE CHILD NUTRITION PROGRAMS SPECIAL MILK PROGRAM FOR CHILDREN § 215.8 Reimbursement payments. (a) (b)(1) The rate of reimbursement per half-pint of milk purchased and (i) served in nonpricing programs... or child care institution. (2) The rate of reimbursement for milk purchased and served free to...
Abstract Continuous glucose monitoring (CGM) systems have been available for more than 15 years by now. However, market uptake is relatively low in most countries; in other words, relatively few patients with diabetes use CGM systems regularly. One major reason for the reluctance of patients to use CGM systems is the costs associated (i.e., in most countries no reimbursement is provided by the health insurance companies). In case reimbursement is in place, like in the United States, only certain patient groups get reimbursement that fulfills strict indications. This situation is somewhat surprising in view of the mounting evidence for benefits of CGM usage from clinical trials: most meta-analyses of these trials consistently show a clinically relevant improvement of glucose control associated with a reduction in hypoglycemic events. More recent trials with CGM systems with an improved CGM technology showed even more impressive benefits, especially if CGM systems are used in different combinations with an insulin pump (e.g., with automated bolus calculators and low glucose suspend features). Nevertheless, sufficient evidence is not available for all patient groups, and more data on cost–efficacy are needed. In addition, good data from real-world studies/registers documenting the benefits of CGM usage under daily life conditions would be of help to convince healthcare systems to cover the costs of CGM systems. In view of the ongoing improvements in established needle-type CGM systems, the fact that new CGM technology will come to the market soon (e.g., implantable sensors), that CGM-like systems are quite successfully at least in certain markets (like the flash glucose monitoring systems), and that the first artificial pancreas systems will come to the market in the next few years, there is a need to make sure that this major improvement in diabetes therapy becomes more widely available for patients with diabetes, for which better reimbursement is essential. PMID
Reimbursement for Continuous Glucose Monitoring.
Heinemann, Lutz; DeVries, J Hans
Continuous glucose monitoring (CGM) systems have been available for more than 15 years by now. However, market uptake is relatively low in most countries; in other words, relatively few patients with diabetes use CGM systems regularly. One major reason for the reluctance of patients to use CGM systems is the costs associated (i.e., in most countries no reimbursement is provided by the health insurance companies). In case reimbursement is in place, like in the United States, only certain patient groups get reimbursement that fulfills strict indications. This situation is somewhat surprising in view of the mounting evidence for benefits of CGM usage from clinical trials: most meta-analyses of these trials consistently show a clinically relevant improvement of glucose control associated with a reduction in hypoglycemic events. More recent trials with CGM systems with an improved CGM technology showed even more impressive benefits, especially if CGM systems are used in different combinations with an insulin pump (e.g., with automated bolus calculators and low glucose suspend features). Nevertheless, sufficient evidence is not available for all patient groups, and more data on cost-efficacy are needed. In addition, good data from real-world studies/registers documenting the benefits of CGM usage under daily life conditions would be of help to convince healthcare systems to cover the costs of CGM systems. In view of the ongoing improvements in established needle-type CGM systems, the fact that new CGM technology will come to the market soon (e.g., implantable sensors), that CGM-like systems are quite successfully at least in certain markets (like the flash glucose monitoring systems), and that the first artificial pancreas systems will come to the market in the next few years, there is a need to make sure that this major improvement in diabetes therapy becomes more widely available for patients with diabetes, for which better reimbursement is essential. PMID:26784130
Bursell, S-E; Zang, S; Keech, A C; Jenkins, A J
Video-based consultation is the only telehealth service reimbursed by the Medicare Benefits Schedule in Australia, but the uptake of telehealth is still low and inconsistent. There is a clear need for the development of appropriate medical evidence to support implementation of telehealth services. With the ubiquitous use of mobile phones, mobile health becomes important in facilitating health services and impacting clinical outcomes anywhere. PMID:27553999
Covering and Reimbursing Telehealth Services.
Policymakers who are striving to achieve better health care, improved health outcomes and lower costs are considering new strategies and technologies. Telehealth is a tool that uses technology to provide health services remotely, and state leaders are looking to it now more than ever as a way to address workforce gaps and reach underserved patients. Among the challenges facing state lawmakers who are working to introduce or expand telehealth is how to handle covering patients and reimbursing providers. PMID:27032126
7 CFR 1485.17 - Reimbursement procedures.
... OF AGRICULTURE LOANS, PURCHASES, AND OTHER OPERATIONS COOPERATIVE AGREEMENTS FOR THE DEVELOPMENT OF FOREIGN MARKETS FOR AGRICULTURAL COMMODITIES Market Access Program § 1485.17 Reimbursement procedures....
48 CFR 719.273-3 - Incentives for prime contractor participation.
... Development (USAID) Mentor-ProtÃ©gÃ© Program 719.273-3 Incentives for prime contractor participation. (a... provides additional guidance. (b) Costs incurred by a Mentor to provide developmental assistance, as... reimbursable as a direct cost under a USAID contract. If USAID is the mentor's responsible audit agency...
We use the introduction of diagnosis related groups (DRGs) in German neonatology to study the determinants of upcoding. Since 2003, reimbursement is based inter alia on birth weight, with substantial discontinuities at eight thresholds. These discontinuities create incentives to upcode preterm infants into classes of lower birth weight. Using data from the German birth statistics 1996-2010 and German hospital data from 2006 to 2011, we show that (1) since the introduction of DRGs, hospitals have upcoded at least 12,000 preterm infants and gained additional reimbursement in excess of 100 million Euro; (2) upcoding rates are systematically higher at thresholds with larger reimbursement hikes and in hospitals that subsequently treat preterm infants, i.e. where the gains accrue; (3) upcoding is systematically linked with newborn health conditional on birth weight. Doctors and midwives respond to financial incentives by not upcoding newborns with low survival probabilities, and by upcoding infants with higher expected treatment costs. PMID:26114589
Bellows, Nicole M; Halpin, Helen A
Objective To examine the relationship between the use of the Minimum Data Set (MDS) for determining Medicaid reimbursement to nursing facilities and the MDS Quality Indicators examining nursing facility residents' mental health. Data Sources The 2004 National MDS facility Quality Indicator reports served as the dependent variables. Explanatory variables were based on the 2004 Online Survey Certification and Reporting system (OSCAR) and an examination of existing reports, a review of the State Medicaid Plans, and State Medicaid personnel. Study Design Multilevel regression models were used to account for the hierarchical structure of the data. Data Collection MDS and OSCAR data were linked by facility identifiers and subsequently linked with state-level variables. Principal Findings The use of the MDS for determining Medicaid reimbursement was associated with higher (poorer) quality indicator values for all four mental health quality indicators examined. This effect was not found in four comparison quality indicators. Conclusions The findings indicate that documentation of mental health symptoms may be influenced by economic incentives. Policy makers should be cautioned from using these measures as the basis for decision making, such as with pay-for-performance initiatives. PMID:18370968
... a space-available basis during both phases of Shuttle operation. The price for this service will be... 14 Aeronautics and Space 5 2010-01-01 2010-01-01 false Reimbursement policy. 1214.202 Section 1214.202 Aeronautics and Space NATIONAL AERONAUTICS AND SPACE ADMINISTRATION SPACE FLIGHT Reimbursement...
... a space-available basis during both phases of Shuttle operation. The price for this service will be... 14 Aeronautics and Space 5 2013-01-01 2013-01-01 false Reimbursement policy. 1214.202 Section 1214.202 Aeronautics and Space NATIONAL AERONAUTICS AND SPACE ADMINISTRATION SPACE FLIGHT Reimbursement...
... a space-available basis during both phases of Shuttle operation. The price for this service will be... 14 Aeronautics and Space 5 2011-01-01 2010-01-01 true Reimbursement policy. 1214.202 Section 1214.202 Aeronautics and Space NATIONAL AERONAUTICS AND SPACE ADMINISTRATION SPACE FLIGHT Reimbursement...
12 CFR 219.3 - Cost reimbursement.
... PROVIDING FINANCIAL RECORDS; RECORDKEEPING REQUIREMENTS FOR CERTAIN FINANCIAL RECORDS (REGULATION S) Reimbursement to Financial Institutions for Providing Financial Records § 219.3 Cost reimbursement. (a) Fees... financial records pertaining to a customer, by written request, through: (i) A court order; (ii) A...
...) To be entitled to reimbursement under this part, each School Food Authority shall submit to the State... reimbursement. (f) Any School Food Authority or child care institution which operates both a nonpricing and... Agriculture Regulations of the Department of Agriculture (Continued) FOOD AND NUTRITION SERVICE, DEPARTMENT...
... 7 Agriculture 4 2014-01-01 2014-01-01 false Reimbursement procedures. 215.10 Section 215.10 Agriculture Regulations of the Department of Agriculture (Continued) FOOD AND NUTRITION SERVICE, DEPARTMENT OF AGRICULTURE CHILD NUTRITION PROGRAMS SPECIAL MILK PROGRAM FOR CHILDREN § 215.10 Reimbursement procedures. (a) To be entitled to...
10 CFR 765.32 - Reimbursement of excess funds.
... 10 Energy 4 2011-01-01 2011-01-01 false Reimbursement of excess funds. 765.32 Section 765.32 Energy DEPARTMENT OF ENERGY REIMBURSEMENT FOR COSTS OF REMEDIAL ACTION AT ACTIVE URANIUM AND THORIUM PROCESSING SITES Additional Reimbursement Procedures § 765.32 Reimbursement of excess funds. (a) No...
... 10 Energy 4 2014-01-01 2014-01-01 false Reimbursement of excess funds. 765.32 Section 765.32 Energy DEPARTMENT OF ENERGY REIMBURSEMENT FOR COSTS OF REMEDIAL ACTION AT ACTIVE URANIUM AND THORIUM PROCESSING SITES Additional Reimbursement Procedures § 765.32 Reimbursement of excess funds. (a) No...
... 10 Energy 4 2013-01-01 2013-01-01 false Reimbursement of excess funds. 765.32 Section 765.32 Energy DEPARTMENT OF ENERGY REIMBURSEMENT FOR COSTS OF REMEDIAL ACTION AT ACTIVE URANIUM AND THORIUM PROCESSING SITES Additional Reimbursement Procedures § 765.32 Reimbursement of excess funds. (a) No...
... 10 Energy 4 2010-01-01 2010-01-01 false Reimbursement of excess funds. 765.32 Section 765.32 Energy DEPARTMENT OF ENERGY REIMBURSEMENT FOR COSTS OF REMEDIAL ACTION AT ACTIVE URANIUM AND THORIUM PROCESSING SITES Additional Reimbursement Procedures § 765.32 Reimbursement of excess funds. (a) No...
... 10 Energy 4 2012-01-01 2012-01-01 false Reimbursement of excess funds. 765.32 Section 765.32 Energy DEPARTMENT OF ENERGY REIMBURSEMENT FOR COSTS OF REMEDIAL ACTION AT ACTIVE URANIUM AND THORIUM PROCESSING SITES Additional Reimbursement Procedures § 765.32 Reimbursement of excess funds. (a) No...
10 CFR 765.10 - Eligibility for reimbursement.
... 10 Energy 4 2013-01-01 2013-01-01 false Eligibility for reimbursement. 765.10 Section 765.10 Energy DEPARTMENT OF ENERGY REIMBURSEMENT FOR COSTS OF REMEDIAL ACTION AT ACTIVE URANIUM AND THORIUM PROCESSING SITES Reimbursement Criteria § 765.10 Eligibility for reimbursement. (a) Any licensee of an...
... 10 Energy 4 2010-01-01 2010-01-01 false Eligibility for reimbursement. 765.10 Section 765.10 Energy DEPARTMENT OF ENERGY REIMBURSEMENT FOR COSTS OF REMEDIAL ACTION AT ACTIVE URANIUM AND THORIUM PROCESSING SITES Reimbursement Criteria § 765.10 Eligibility for reimbursement. (a) Any licensee of an...
... 10 Energy 4 2011-01-01 2011-01-01 false Eligibility for reimbursement. 765.10 Section 765.10 Energy DEPARTMENT OF ENERGY REIMBURSEMENT FOR COSTS OF REMEDIAL ACTION AT ACTIVE URANIUM AND THORIUM PROCESSING SITES Reimbursement Criteria § 765.10 Eligibility for reimbursement. (a) Any licensee of an...
... 10 Energy 4 2012-01-01 2012-01-01 false Eligibility for reimbursement. 765.10 Section 765.10 Energy DEPARTMENT OF ENERGY REIMBURSEMENT FOR COSTS OF REMEDIAL ACTION AT ACTIVE URANIUM AND THORIUM PROCESSING SITES Reimbursement Criteria § 765.10 Eligibility for reimbursement. (a) Any licensee of an...
Dachman, Abraham H; Yee, Judy
CT colonography has been shown to be an effective method to screen for colorectal cancer. However, at present, full endorsement and reimbursement for screening CT colonography, particularly by the US Preventive Services Task Force and CMS, respectively, are absent, so this screening option is infrequently used, and optical colonoscopy remains the de facto standard screening option. The authors summarize the past accomplishments that led to the current state of reimbursement and outline the remaining challenges and road to full acceptance and reimbursement of screening CT colonography nationally. PMID:24295944
Breitkopf, Carmen Radecki; Loza, Melissa; Vincent, Kathleen; Moench, Thomas; Stanberry, Lawrence R.; Rosenthal, Susan L.
A greater understanding of participant views regarding reimbursement will help investigators plan studies that have better potential for reaching target enrollment, maximize efficient recruitment, maintain scientific integrity, and enhance retention over time. As part of a clinical trial in the area of sexual health, healthy women’s perceptions of reimbursement for research participation were investigated. Semi-structured, audio-recorded, qualitative interviews were conducted immediately upon women’s completion of the clinical trial to enable a participant-driven understanding of perceptions about monetary reimbursement. Audio-recordings were transcribed and analyzed using framework analysis. Women (N = 30) had a mean age of 29.5 ± 5.7 years (range 22–45 years). Sixty-three percent of participants (n = 19) were non-Hispanic (white n = 13, black n = 4, and Asian n = 2), while the remaining were Hispanic (n = 11). Seventy-three percent (n = 22) reported previous participation in research. In general, women viewed reimbursement as a benefit to research participation, the amount of which should reflect time, the inconvenience to the research subject, and the potential for unknown risks in the short- and long-term. They believed reimbursement should take into account the degree of risk of the study, with investigations of experimental products offering greater reimbursement. Women believed that monetary reimbursement is unlikely to coerce an individual to volunteer for a study involving procedures or requirements that they found unacceptable. The results of this study can be used to provide guidance to those planning and evaluating reimbursement for research participation. PMID:21931235
[Companion diagnostics and reimbursement system].
Tazawa, Yoshiaki
Recently, Companion Diagnostics (CoDx) have been gaining importance to promote personalized medicine in order to improve the safety and cost effectiveness of therapy. In July 2011, the FDA published draft guidance for the development of CoDx, which recommends the co-development of CoDx and new drugs as the best practice, and then the FDA approved vemurafenib and the BRAF-V600-E gene mutation assay simultaneously as a typical example of the co-development of a new drug and its CoDx. Considering medical needs for multiple biomarker assays to select the right assay from various therapeutic candidates, more complicated assay technologies such as DNA sequencing will be required for CoDx in the near future. However, since it is quite difficult to standardize the validation process and manage test quality under the current regulatory criteria of in-vitro diagnostics using advanced and/or complicated assay technologies, the clinical use of laboratory-developed tests (LDT) should be recommended in order to avoid biomarker test lag. On the other hand, the current reimbursement system is not always suitable to assess the clinical and technological value of CoDx and it should be revised to encourage the development of CoDx. Although Health Technology Assessment (HTA) is a potential method to assess the value of CoDx, it is not easy to define appropriate indicators for CoDx because its clinical utility and cost effectiveness are completely dependent on the performance and value of available therapy. It is also suggested that the price and/or insurance rate of CoDx should be included in the price of the drug; however, there is no good solution to how to pay for CoDx with negative results for all therapies. It is said that the concept of personalized medicine with advanced technologies is a destructive innovation that could markedly change the current structure and system of medications; therefore, it is essential to create a quite new regulatory and reimbursement system to
Purpose of the Study: To examine how Medicaid capital reimbursement policy is associated with nursing homes (NHs) having high proportions of private rooms and small households. Design and Methods: Through a 2009/2010 NH national survey, we identified NHs having small households and high proportions of private rooms (≥76%). A survey of state Medicaid officials and policy document review provided 2009 policy data. Facility- and county-level covariates were from Online Survey, Certification and Reporting, the Area Resource File, and aggregated resident assessment data (minimum data set). The policy of interest was the presence of traditional versus fair rental capital reimbursement policy. Average Medicaid per diem rates and the presence of NH pay-for-performance (p4p) reimbursement were also examined. A total of 1,665 NHs in 40 states were included. Multivariate logistic regression analyses (with clustering on states) were used. Results: In multivariate models, Medicaid capital reimbursement policy was not significantly associated with either outcome. However, there was a significantly greater likelihood of NHs having many private rooms when states had higher Medicaid rates (per $10 increment; adjusted odds ratio [AOR] 1.13; 95% CI 1.049, 1.228), and in states with versus without p4p (AOR 1.78; 95% CI 1.045, 3.036). Also, in states with p4p NHs had a greater likelihood of having small households (AOR 1.78; 95% CI 1.045, 3.0636). Implications: Higher NH Medicaid rates and reimbursement incentives may contribute to a higher presence of 2 important environmental artifacts of culture change—an abundance of private rooms and small households. However, longitudinal research examining policy change is needed to establish the cause and effect of the associations observed. PMID:24443609
... 7 Agriculture 6 2011-01-01 2011-01-01 false Research and development reimbursement, maintenance... Submission of Policies, Provisions of Policies and Rates of Premium § 400.712 Research and development... submission may be eligible for a one-time payment of research and development costs and reimbursement...
42 CFR 413.88 - Incentive payments under plans for voluntary reduction in number of medical residents.
... 42 Public Health 2 2013-10-01 2013-10-01 false Incentive payments under plans for voluntary reduction in number of medical residents. 413.88 Section 413.88 Public Health CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES MEDICARE PROGRAM PRINCIPLES OF REASONABLE COST REIMBURSEMENT; PAYMENT FOR END-STAGE...
Diabetes device reimbursement in the EU-5.
Schäfer, Elmar; Schnell, Gerald; Bobáková, Tamara
The reimbursement landscape for new and innovative diabetes devices in Europe is very heterogeneous and nontransparent, with each country employing different mechanisms, pathways, and requirements. This article provides an overview of how diabetes device reimbursement works in the outpatient setting in the five major European Union markets (France, Germany, Italy, Spain, and the United Kingdom; the EU-5). It will be of particular interest to manufacturers of innovative devices. Markets are first categorized as either a centralized or a regionalized reimbursement decision-making system, and implications for device reimbursement are explored. In the second part, specific requirements and success factors for wide reimbursement in the EU-5 are analyzed in detail. Gaining early acceptance by the main influencers (key opinion leaders and payers) is the first step. Equally important is the provision of convincing evidence, be this clinical, health-economic (cost-effectiveness), or a demonstration of cost savings (budget impact). In some countries, local usage data may be a requirement as well. Lastly, as payers' willingness to pay stems directly from their perceived value of a device, a key success factor and a necessary precondition for manufacturers is to set the right price. PMID:23911192
Analysis of nursing home capital reimbursement systems
Boerstler, Heidi; Carlough, Tom; Schlenker, Robert E.
An increasing number of States are using a fair-rental approach for reimbursement of nursing home capital costs. In this study, two variants of the fair-rental capital-reimbursement approach are compared with the traditional cost-based approach in terms of after-tax cash flow to the investor, cost to the State, and rate of return to investor. Simulation models were developed to examine the effects of each capital-reimbursement approach both at specific points in time and over various periods of time. Results indicate that although long-term costs were similar for the three systems, both fair-rental approaches may be superior to the traditional cost-based approach in promoting and controlling industry stability and, at the same time, in providing an adequate return to investors. PMID:10110878
Medicaid reimbursement, prenatal care and infant health.
This paper evaluates the impact of state-level Medicaid reimbursement rates for obstetric care on prenatal care utilization across demographic groups. It also uses these rates as an instrumental variable to assess the importance of prenatal care on birth weight. The analysis is conducted using a unique dataset of Medicaid reimbursement rates and 2001-2010 Vital Statistics Natality data. Conditional on county fixed effects, the study finds a modest, but statistically significant positive relationship between Medicaid reimbursement rates and the number of prenatal visits obtained by pregnant women. Additionally, higher rates are associated with an increase in the probability of obtaining adequate care, as well as a reduction in the incidence of going without any prenatal care. However, the effect of an additional prenatal visit on birth weight is virtually zero for black disadvantaged mothers, while an additional visit yields a substantial increase in birth weight of over 20 g for white disadvantaged mothers. PMID:26355229
10 CFR 765.20 - Procedures for submitting reimbursement claims.
... AND THORIUM PROCESSING SITES Procedures for Submitting and Processing Reimbursement Claims § 765.20... reimbursement ceiling for any active uranium or thorium processing site; (5) Any revision in the per dry...
... SERVICE, DEPARTMENT OF AGRICULTURE CHILD NUTRITION PROGRAMS NATIONAL SCHOOL LUNCH PROGRAM Reimbursement... lunches served to children under the National School Lunch Program and special cash assistance payments... National School Lunch and Commodity School Programs. Reimbursement payments shall also be made......
14 CFR 331.7 - What losses will be reimbursed?
... eligible reimbursement period. If you did not forecast for the eligible reimbursement period or any part of.... (g) Your calculation of revenues, expenses and income must be based on financial documents...
20 CFR 404.999b - Who may be reimbursed.
... Decisions Payment of Certain Travel Expenses § 404.999b Who may be reimbursed. (a) The following individuals may be reimbursed for certain travel expenses— (1) You, when you attend medical examinations...
20 CFR 416.1496 - Who may be reimbursed.
... Decisions Payment of Certain Travel Expenses § 416.1496 Who may be reimbursed. (a) The following individuals may be reimbursed for certain travel expenses— (1) You, when you attend medical examinations...
23 CFR 645.117 - Cost development and reimbursement.
... consistent with the provisions of 48 CFR part 31. (2) Costs not eligible for Federal reimbursement include... 23 Highways 1 2011-04-01 2011-04-01 false Cost development and reimbursement. 645.117 Section 645... OPERATIONS UTILITIES Utility Relocations, Adjustments, and Reimbursement § 645.117 Cost development...
... consistent with the provisions of 48 CFR part 31. (2) Costs not eligible for Federal reimbursement include... 23 Highways 1 2010-04-01 2010-04-01 false Cost development and reimbursement. 645.117 Section 645... OPERATIONS UTILITIES Utility Relocations, Adjustments, and Reimbursement § 645.117 Cost development...
14 CFR § 1214.803 - Reimbursement policy.
... 14 Aeronautics and Space 5 2014-01-01 2014-01-01 false Reimbursement policy. Â§ 1214.803 Section Â§ 1214.803 Aeronautics and Space NATIONAL AERONAUTICS AND SPACE ADMINISTRATION SPACE FLIGHT Reimbursement... shall be escalated in accordance with the Shuttle policy. (c) Customers shall reimburse NASA an...
7 CFR 220.10 - Effective date for reimbursement.
..., DEPARTMENT OF AGRICULTURE CHILD NUTRITION PROGRAMS SCHOOL BREAKFAST PROGRAM § 220.10 Effective date for reimbursement. Reimbursement payments under the School Breakfast Program may be made only to School Food... execution of the agreement. Such payments may include reimbursement in connection with breakfasts served...
... CONTRACT MANAGEMENT QUALITY ASSURANCE Contract Clauses 46.303 Cost-reimbursement supply contracts. The contracting officer shall insert the clause at 52.246-3, Inspection of Supplies—Cost-Reimbursement, in... 48 Federal Acquisition Regulations System 1 2010-10-01 2010-10-01 false Cost-reimbursement...
7 CFR 1484.56 - How are Cooperators reimbursed?
... Director, Marketing Operations Staff, FAS, USDA. (c) FAS will not reimburse claims submitted later than 6 months after the end of a marketing plan year. (d) If FAS overpays a reimbursement claim, the Cooperator... reimbursement claims is available from the Director, Marketing Operations Staff, FAS, USDA. Claims...
....S. office to the Director, Marketing Operations Staff, FAS, USDA. (c) FAS will not reimburse claims submitted later than 6 months after the end of a marketing plan year. (d) If FAS overpays a reimbursement... format for reimbursement claims is available from the Director, Marketing Operations Staff, FAS,...
40 CFR 310.5 - Am I eligible for reimbursement?
... 40 Protection of Environment 29 2013-07-01 2013-07-01 false Am I eligible for reimbursement? 310.5 Section 310.5 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) SUPERFUND, EMERGENCY... HAZARDOUS SUBSTANCE RELEASES Provisions Who Can Be Reimbursed? § 310.5 Am I eligible for reimbursement?...
... 40 Protection of Environment 29 2012-07-01 2012-07-01 false Am I eligible for reimbursement? 310.5 Section 310.5 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) SUPERFUND, EMERGENCY... HAZARDOUS SUBSTANCE RELEASES Provisions Who Can Be Reimbursed? § 310.5 Am I eligible for reimbursement?...
... 40 Protection of Environment 28 2014-07-01 2014-07-01 false Am I eligible for reimbursement? 310.5 Section 310.5 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) SUPERFUND, EMERGENCY... HAZARDOUS SUBSTANCE RELEASES Provisions Who Can Be Reimbursed? § 310.5 Am I eligible for reimbursement?...
... 40 Protection of Environment 27 2010-07-01 2010-07-01 false Am I eligible for reimbursement? 310.5 Section 310.5 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) SUPERFUND, EMERGENCY... HAZARDOUS SUBSTANCE RELEASES Provisions Who Can Be Reimbursed? § 310.5 Am I eligible for reimbursement?...
... 40 Protection of Environment 28 2011-07-01 2011-07-01 false Am I eligible for reimbursement? 310.5 Section 310.5 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) SUPERFUND, EMERGENCY... HAZARDOUS SUBSTANCE RELEASES Provisions Who Can Be Reimbursed? § 310.5 Am I eligible for reimbursement?...
28 CFR 94.23 - Amount of reimbursement.
... 28 Judicial Administration 2 2010-07-01 2010-07-01 false Amount of reimbursement. 94.23 Section 94.23 Judicial Administration DEPARTMENT OF JUSTICE (CONTINUED) CRIME VICTIM SERVICES International Terrorism Victim Expense Reimbursement Program Coverage § 94.23 Amount of reimbursement....
... 7 Agriculture 10 2014-01-01 2014-01-01 false Compensation and reimbursement. 1230.38 Section 1230... National Pork Producers Delegate Body § 1230.38 Compensation and reimbursement. The members of the Delegate Body shall serve without compensation but may be reimbursed by the Board for actual...
7 CFR 1230.57 - Compensation and reimbursement.
... 7 Agriculture 10 2013-01-01 2013-01-01 false Compensation and reimbursement. 1230.57 Section 1230... National Pork Board § 1230.57 Compensation and reimbursement. The members of the Board shall serve without compensation but shall be reimbursed for reasonable expenses incurred by them in the exercise of their...
... 7 Agriculture 10 2011-01-01 2011-01-01 false Compensation and reimbursement. 1230.38 Section 1230... National Pork Producers Delegate Body § 1230.38 Compensation and reimbursement. The members of the Delegate Body shall serve without compensation but may be reimbursed by the Board for actual...
... 7 Agriculture 10 2013-01-01 2013-01-01 false Compensation and reimbursement. 1230.38 Section 1230... National Pork Producers Delegate Body § 1230.38 Compensation and reimbursement. The members of the Delegate Body shall serve without compensation but may be reimbursed by the Board for actual...
... 7 Agriculture 10 2014-01-01 2014-01-01 false Compensation and reimbursement. 1230.57 Section 1230... National Pork Board § 1230.57 Compensation and reimbursement. The members of the Board shall serve without compensation but shall be reimbursed for reasonable expenses incurred by them in the exercise of their...
... 7 Agriculture 10 2010-01-01 2010-01-01 false Compensation and reimbursement. 1230.38 Section 1230... National Pork Producers Delegate Body § 1230.38 Compensation and reimbursement. The members of the Delegate Body shall serve without compensation but may be reimbursed by the Board for actual...
... 7 Agriculture 10 2012-01-01 2012-01-01 false Compensation and reimbursement. 1230.57 Section 1230... National Pork Board § 1230.57 Compensation and reimbursement. The members of the Board shall serve without compensation but shall be reimbursed for reasonable expenses incurred by them in the exercise of their...
... 7 Agriculture 10 2010-01-01 2010-01-01 false Compensation and reimbursement. 1230.57 Section 1230... National Pork Board § 1230.57 Compensation and reimbursement. The members of the Board shall serve without compensation but shall be reimbursed for reasonable expenses incurred by them in the exercise of their...
... 7 Agriculture 10 2011-01-01 2011-01-01 false Compensation and reimbursement. 1230.57 Section 1230... National Pork Board § 1230.57 Compensation and reimbursement. The members of the Board shall serve without compensation but shall be reimbursed for reasonable expenses incurred by them in the exercise of their...
... 28 Judicial Administration 2 2013-07-01 2013-07-01 false Amount of reimbursement. 94.23 Section 94.23 Judicial Administration DEPARTMENT OF JUSTICE (CONTINUED) CRIME VICTIM SERVICES International Terrorism Victim Expense Reimbursement Program Coverage § 94.23 Amount of reimbursement....
... 28 Judicial Administration 2 2012-07-01 2012-07-01 false Amount of reimbursement. 94.23 Section 94.23 Judicial Administration DEPARTMENT OF JUSTICE (CONTINUED) CRIME VICTIM SERVICES International Terrorism Victim Expense Reimbursement Program Coverage § 94.23 Amount of reimbursement....
... 28 Judicial Administration 2 2011-07-01 2011-07-01 false Amount of reimbursement. 94.23 Section 94.23 Judicial Administration DEPARTMENT OF JUSTICE (CONTINUED) CRIME VICTIM SERVICES International Terrorism Victim Expense Reimbursement Program Coverage § 94.23 Amount of reimbursement....
... 28 Judicial Administration 2 2014-07-01 2014-07-01 false Amount of reimbursement. 94.23 Section 94.23 Judicial Administration DEPARTMENT OF JUSTICE (CONTINUED) CRIME VICTIM SERVICES International Terrorism Victim Expense Reimbursement Program Coverage § 94.23 Amount of reimbursement....
... policy language will be eligible for a higher reimbursement than policies or plans of insurance for... miscellaneous expenses, other costs, and the total cost); (vi) Software and computer programming...
Salary Reimbursement--Benefits and Costs.
The policies of most research-oriented universities with regard to reimbursement for faculty time from grants and contracts can probably be summed up in a single sentence: "Let's get as much as we can." Several areas of concern arise from this situation: (1) the university's ability to plan its future, develop real goals and objectives, govern and…
44 CFR 352.28 - Reimbursement.
... 44 Emergency Management and Assistance 1 2010-10-01 2010-10-01 false Reimbursement. 352.28 Section 352.28 Emergency Management and Assistance FEDERAL EMERGENCY MANAGEMENT AGENCY, DEPARTMENT OF HOMELAND SECURITY PREPAREDNESS COMMERCIAL NUCLEAR POWER PLANTS: EMERGENCY PREPAREDNESS PLANNING...
... Travel Regulations (41 CFR parts 301 through 304) for no more than two representatives of a single brand... reimburse per diem in excess of the rates allowed under the U.S. Federal Travel Regulations (41 CFR parts... Travel Regulations (41 CFR parts 301 through 304); (12) An overseas office, including rent,...
7 CFR 220.11 - Reimbursement procedures.
... Lunch Program and the School Breakfast Program, the State agency or FNSRO, where applicable, may... AGRICULTURE CHILD NUTRITION PROGRAMS SCHOOL BREAKFAST PROGRAM § 220.11 Reimbursement procedures. (a) To be... provide the Reports of School Program Operations required under § 220.13(b)(2). Unless otherwise...
... 7 Agriculture 10 2011-01-01 2011-01-01 false Reimbursement procedures. 1485.17 Section 1485.17 Agriculture Regulations of the Department of Agriculture (Continued) COMMODITY CREDIT CORPORATION, DEPARTMENT OF AGRICULTURE LOANS, PURCHASES, AND OTHER OPERATIONS COOPERATIVE AGREEMENTS FOR THE DEVELOPMENT OF FOREIGN MARKETS FOR...
7 CFR 220.9 - Reimbursement payments.
... AGRICULTURE CHILD NUTRITION PROGRAMS SCHOOL BREAKFAST PROGRAM § 220.9 Reimbursement payments. (a) State... breakfasts meeting the requirements of § 220.8, and reported in accordance with § 220.11(b) of this part. School Food Authorities shall plan for and prepare breakfasts on the basis of participation trends,...
12 CFR 1011.5 - Reimbursement.
... 12 Banks and Banking 8 2014-01-01 2014-01-01 false Reimbursement. 1011.5 Section 1011.5 Banks and Banking BUREAU OF CONSUMER FINANCIAL PROTECTION PURCHASERS' REVOCATION RIGHTS, SALES PRACTICES AND... condition, the developer may subtract from the amount paid by the purchaser, and otherwise due to...
... 12 Banks and Banking 8 2013-01-01 2013-01-01 false Reimbursement. 1011.5 Section 1011.5 Banks and Banking BUREAU OF CONSUMER FINANCIAL PROTECTION PURCHASERS' REVOCATION RIGHTS, SALES PRACTICES AND... condition, the developer may subtract from the amount paid by the purchaser, and otherwise due to...
... 12 Banks and Banking 8 2012-01-01 2012-01-01 false Reimbursement. 1011.5 Section 1011.5 Banks and Banking BUREAU OF CONSUMER FINANCIAL PROTECTION PURCHASERS' REVOCATION RIGHTS, SALES PRACTICES AND... condition, the developer may subtract from the amount paid by the purchaser, and otherwise due to...
Indirect Cost Reimbursement: An Industrial View.
The meaning of indirect costs in an industrial environment is discussed. Other factors considered are corporate policies; nature of work being supported; the uniqueness of the work; who is doing the negotiating for industry; and indirect rates. Suggestions are offered for approaches to indirect cost reimbursement. (Author/MLW)
Implementation of the 2011 Reimbursement Act in Poland: Desired and undesired effects of the changes in reimbursement policy.
Kawalec, Paweł; Sagan, Anna; Stawowczyk, Ewa; Kowalska-Bobko, Iwona; Mokrzycka, Anna
The Act of 12 May 2011 on the Reimbursement of Medicines, Foodstuffs Intended for Particular Nutritional Uses and Medical Devices constitutes a major change of the reimbursement policy in Poland. The main aims of this Act were to rationalize the reimbursement policy and to reduce spending on reimbursed drugs. The Act seems to have met these goals: reimbursement policy (including pricing of reimbursed drugs) was overhauled and the expenditure of the National Health Fund on reimbursed drugs saw a significant decrease in the year following the Act's introduction. The annual savings achieved since then (mainly due to the introduction of risk sharing schemes), have made it possible to include new drugs into the reimbursement list and improve access to innovative drugs. However, at the same time, the decrease in prices of reimbursed drugs, that the Act brought about, led to an uncontrolled outflow of some of these drugs abroad and shortages in Poland. This paper analyses the main changes introduced by the Reimbursement Act and their implications. Since the Act came into force relatively recently, its full impact on the reimbursement policy is not yet possible to assess. PMID:26994865
[Alternatives to pharmaceutical distribution and reimbursement].
Meneu, R
In Spain pharmaceutical distribution is carried out mainly thorugh the 20,000 independent pharmacies located throughout the country. This situation contrasts with that in other countries where other health care providers play a major role in drug dispensation or where pharmacies form part of industrial conglomerates or commercial chains. We describe the pharmaceutical distribution chain in Spain wholesale and through the pharmacies and place particular emphasis on five aspects of relevance when considering alternatives: ownership of the pharmacy and norms of professional service, criteria for setting up a pharmacy, monopoly on dispensing, automatic ageement with the Spanish national health system and reimbursement system. Several alternatives found in comparable countries are described: mail order and on-line distribution, sale of over-the counter pharmaceutical products in establishments other than pharmacies, the estabilishment of pharmaceutical chains, dispensing by providers, the repercussions of electronic prescribing and the possibilities of the still-emerging Pharmacuetical Care. The characteristics of pharmacy reimbursement systems are also reviewed. We recommend modification of limitations on ownership of pharmacies, the establishment of optional agreements between pharmacies and the Spanish national health system and the authorization of alternative or complementary channels of distribution for some products. We propose a mixed model of reimbursement that would include: a) a ficed price for dispensing; b) almost total return of the cost of the product; c) reimbursement for services explicity defined by the financer, and d) the possibility of a selective fixed payment for certain situations depending on the agreed services or a guaranteed minimum income. PMID:11958754
Background In mainland China, the motivation behind voluntary blood donation is a relatively new and understudied behavior. In recent times provincial governments in China have implemented various institutional incentive measures. However, little is known regarding the effectiveness of such measures. This qualitative study investigated the nature and outcomes of some identified institutionalized mechanisms, in particular how these were created and distributed in the form of incentives for voluntary blood donation. Methods Participatory observations were conducted at two blood donation stations and four blood collecting vehicles in Changsha city, China. In-depth interviews were conducted with 17 staff and 58 blood donors at the aforementioned venues from May to October 2008 in Changsha. Results Thematic analysis revealed the operation of four primary type incentives: policy-driven, symbolic, information feedback and role models, which constituted the system of institutional incentives. The current blood reimbursement system was not the primary motivation for blood donation; instead this system was a subtheme of future assurance for emergency blood needs. It was evident that symbolic incentives stressed the meaning and value of blood donation. Furthermore, post-donation information services and the inherent mechanisms of communication, enhanced by some public role models, served to draw the public to donate blood. Conclusions At the institutional level, blood donation was not only informed by altruism, but also carried a system of benefit and reward for the donors and their family members. We would recommend that such arrangements, if accommodated effectively into China’s health promotion strategies, would increase the likelihood of blood donation. PMID:23721212
7 CFR 1214.45 - Compensation and reimbursement.
... TREE PROMOTION, RESEARCH, AND INFORMATION ORDER Christmas Tree Promotion, Research, and Information Order Christmas Tree Promotion Board § 1214.45 Compensation and reimbursement. The members of the...
7 CFR 1208.46 - Compensation and reimbursement.
... RASPBERRY PROMOTION, RESEARCH, AND INFORMATION ORDER Processed Raspberry Promotion, Research, and Information Order National Processed Raspberry Council § 1208.46 Compensation and reimbursement. The...
78 FR 36035 - Proposed Information Collection Activity: [Beneficiary Travel Mileage Reimbursement Application...
... beneficiary travel mileage reimbursement benefit in an efficient, convenient and accurate manner. VHA must... AFFAIRS Proposed Information Collection Activity: [Beneficiary Travel Mileage Reimbursement Application... to ``OMB Control No. 2900--NEW (Beneficiary Travel Mileage Reimbursement Application Form)'' in...
... development costs must be supported by itemized statements and supporting documentation (copies of contracts... all persons who make up the contracted party who had a substantive involvement in the development of... 7 Agriculture 6 2014-01-01 2014-01-01 false Research and development reimbursement,...
76 FR 39043 - TRICARE; Reimbursement of Sole Community Hospitals and Adjustment to Reimbursement of Critical...
... reimburses SCHs for inpatient care the greatest of these aggregate amounts: 1. What the SCH would have been... conform to the statute. Under 32 CFR 199.14(a)(1)(ii)(D)(6), SCHs are exempt from the TRICARE DRG-based... than 20 TRICARE discharges annually. The TRICARE average cost per discharge in 1 year may not be a...
Bundled-rate legislation for Medicare reimbursement for dialysis services: implications for anemia management with ESAs.
With the incidence of ESRD on the rise, there is a continuing need to control anemia-related treatment costs in dialysis patients receiving reimbursement through Medicare. Currently, erythropoiesis-stimulating agents (ESAs) are billed separately from dialysis services, potentially creating little financial incentive for more efficient use. The Medicare Improvement for Patients and Providers Act, passed by the U.S. Congress in July 2008, includes provisions intended to address this concern. Under this act, dialysis services will be reimbursed using a fully bundled, comprehensive payment system that includes all services currently covered in the basic composite rate, as well as certain separately billable items, including ESAs. A base rate of $229.63 per treatment has been assigned, to be individualized using case-mix adjusters. The implications of this new system for anemia management with ESAs continue to be elucidated. With fixed compensation for ESAs, management strategies that maximize efficiencies and, thereby, optimize cost savings will be favored. Select strategies may include switching from intravenous (IV) to subcutaneous routes, lowering Hb targets and ESA doses in hyporesponsive patients, increasing administration of IV iron, increasing use of home dialysis, and optimizing ESA dosing intervals. Once-monthly ESA therapy has potential advantages under this new system as an alternative to more frequently administered ESAs and may help achieve quality metrics in a cost-efficient manner. PMID:21071515
Shikora, Scott A; Kruger, Rayford S; Blackburn, George L; Fallon, John A; Harvey, Alan M; Johnson, Elvira Q; Kaplan, Lee; Mun, Edward C; Riley, Stancel; Robinson, Malcolm K; Sabin, James E; Snow, Roger L; Lonigro, Robert; Steingisser, Lee J; Lautz, David B
To update evidence-based best practice guidelines for coding and reimbursement and establish policy and access standards for weight loss surgery (WLS). Systematic search of English-language literature on WLS and health-care policy, access, insurance reimbursement, coding, private payers, public policy, and mandated benefits published between April 2004 and May 2007 in MEDLINE, EMBASE, and the Cochrane Library. Use of key words to narrow the search for a selective review of abstracts, retrieval of full articles, and grading of evidence according to systems used in established evidence-based models. We identified 51 publications in our literature search; the 20 most relevant were examined in detail. These included reviews, cost-benefit analyses, and trend and cost studies from administrative databases. Literature on policy issues surrounding WLS are very sparse and largely focused on economic analyses. Reports on policy initiatives in the public and private arenas are primarily limited to narrative reviews of nonsurgical efforts to fight obesity. A substantial body of work shows that WLS improves or reverses most obesity-related comorbidities. Mounting evidence also indicates that WLS confers a significant survival advantage for those who undergo it. WLS is a viable and cost-effective treatment for an increasingly common disease, and policy decisions are more frequently being linked to incentives for national health-care goals. However, access to WLS often varies by payer and region. Currently, there are no uniform criteria for determining patient appropriateness for surgery. PMID:19396072
14 CFR 331.13 - What is the eligible reimbursement period under this part?
... TRANSPORTATION (AVIATION PROCEEDINGS) PROCEDURAL REGULATIONS PROCEDURES FOR REIMBURSEMENT OF GENERAL AVIATION... reimbursement. The first period is from September 11, 2001 until May 16, 2002. The second period is...
... 10 Energy 4 2014-01-01 2014-01-01 false Eligibility for reimbursement. 765.10 Section 765.10 Energy DEPARTMENT OF ENERGY REIMBURSEMENT FOR COSTS OF REMEDIAL ACTION AT ACTIVE URANIUM AND THORIUM... uranium or thorium processing site that has incurred costs of remedial action for the site that...
45 CFR 149.315 - Reimbursement conditioned upon available funds.
... 45 Public Welfare 1 2014-10-01 2014-10-01 false Reimbursement conditioned upon available funds. 149.315 Section 149.315 Public Welfare Department of Health and Human Services REQUIREMENTS RELATING TO HEALTH CARE ACCESS REQUIREMENTS FOR THE EARLY RETIREE REINSURANCE PROGRAM Reimbursement...
... 45 Public Welfare 1 2012-10-01 2012-10-01 false Reimbursement conditioned upon available funds. 149.315 Section 149.315 Public Welfare DEPARTMENT OF HEALTH AND HUMAN SERVICES REQUIREMENTS RELATING TO HEALTH CARE ACCESS REQUIREMENTS FOR THE EARLY RETIREE REINSURANCE PROGRAM Reimbursement...
... 45 Public Welfare 1 2013-10-01 2013-10-01 false Reimbursement conditioned upon available funds. 149.315 Section 149.315 Public Welfare DEPARTMENT OF HEALTH AND HUMAN SERVICES REQUIREMENTS RELATING TO HEALTH CARE ACCESS REQUIREMENTS FOR THE EARLY RETIREE REINSURANCE PROGRAM Reimbursement...
... 45 Public Welfare 1 2010-10-01 2010-10-01 false Reimbursement conditioned upon available funds. 149.315 Section 149.315 Public Welfare DEPARTMENT OF HEALTH AND HUMAN SERVICES REQUIREMENTS RELATING TO HEALTH CARE ACCESS REQUIREMENTS FOR THE EARLY RETIREE REINSURANCE PROGRAM Reimbursement...
... 45 Public Welfare 1 2011-10-01 2011-10-01 false Reimbursement conditioned upon available funds. 149.315 Section 149.315 Public Welfare DEPARTMENT OF HEALTH AND HUMAN SERVICES REQUIREMENTS RELATING TO HEALTH CARE ACCESS REQUIREMENTS FOR THE EARLY RETIREE REINSURANCE PROGRAM Reimbursement...
22 CFR 202.7 - Documentation required for reimbursement.
... 22 Foreign Relations 1 2010-04-01 2010-04-01 false Documentation required for reimbursement. 202.7 Section 202.7 Foreign Relations AGENCY FOR INTERNATIONAL DEVELOPMENT OVERSEAS SHIPMENTS OF SUPPLIES BY VOLUNTARY NON-PROFIT RELIEF AGENCIES § 202.7 Documentation required for reimbursement. Claims...
... 34 Education 3 2010-07-01 2010-07-01 false Reimbursement to the Fund. 674.13 Section 674.13 Education Regulations of the Offices of the Department of Education (Continued) OFFICE OF POSTSECONDARY EDUCATION, DEPARTMENT OF EDUCATION FEDERAL PERKINS LOAN PROGRAM General Provisions § 674.13 Reimbursement...
14 CFR § 1214.202 - Reimbursement policy.
... 14 Aeronautics and Space 5 2014-01-01 2014-01-01 false Reimbursement policy. Â§ 1214.202 Section Â§ 1214.202 Aeronautics and Space NATIONAL AERONAUTICS AND SPACE ADMINISTRATION SPACE FLIGHT Reimbursement for Shuttle Services Provided to Civil U.S. Government Users and Foreign Users Who Have...
... 38 Pensions, Bonuses, and Veterans' Relief 1 2014-07-01 2014-07-01 false Submittal of claim for reimbursement. 17.114 Section 17.114 Pensions, Bonuses, and Veterans' Relief DEPARTMENT OF VETERANS AFFAIRS MEDICAL Reimbursement for Loss by Natural Disaster of Personal Effects of Hospitalized Or Nursing...
... 38 Pensions, Bonuses, and Veterans' Relief 1 2013-07-01 2013-07-01 false Submittal of claim for reimbursement. 17.114 Section 17.114 Pensions, Bonuses, and Veterans' Relief DEPARTMENT OF VETERANS AFFAIRS MEDICAL Reimbursement for Loss by Natural Disaster of Personal Effects of Hospitalized Or Nursing...
36 CFR 64.15 - Financial reporting requirements and reimbursements.
... requirements and reimbursements. 64.15 Section 64.15 Parks, Forests, and Public Property NATIONAL PARK SERVICE... RIGHTS-OF-WAY § 64.15 Financial reporting requirements and reimbursements. Payments to applicants will... approved project. Advances shall be limited to one month's cash requirements. The request for advance...
32 CFR 199.14 - Provider reimbursement methods.
... 32 National Defense 2 2013-07-01 2013-07-01 false Provider reimbursement methods. 199.14 Section 199.14 National Defense Department of Defense (Continued) OFFICE OF THE SECRETARY OF DEFENSE (CONTINUED) MISCELLANEOUS CIVILIAN HEALTH AND MEDICAL PROGRAM OF THE UNIFORMED SERVICES (CHAMPUS) § 199.14 Provider reimbursement methods. (a) Hospitals....
... 48 Federal Acquisition Regulations System 2 2010-10-01 2010-10-01 false Termination (Cost....249-6 Termination (Cost-Reimbursement). As prescribed in 49.503(a)(1), insert the following clause: Termination (Cost-Reimbursement) (MAY 2004) (a) The Government may terminate performance of work under...
... 48 Federal Acquisition Regulations System 6 2010-10-01 2010-10-01 true Travel approvals and....215-77 Travel approvals and reimbursement. As prescribed at 2015.209-70(d), the contracting officer shall insert the following clause in cost reimbursement solicitations and contracts which require...
... 48 Federal Acquisition Regulations System 6 2014-10-01 2014-10-01 false Travel approvals and....215-77 Travel approvals and reimbursement. As prescribed at 2015.209-70(d), the contracting officer shall insert the following clause in cost reimbursement solicitations and contracts which require...
... 48 Federal Acquisition Regulations System 6 2012-10-01 2012-10-01 false Travel approvals and....215-77 Travel approvals and reimbursement. As prescribed at 2015.209-70(d), the contracting officer shall insert the following clause in cost reimbursement solicitations and contracts which require...